Sofosbuvir is indicated for treatment of chronic hepatitis C virus (HCV) infection as an ANTIVIRAL AGENT in the treatment for patients with HCV mono-infection and HCV/HIV-1 co-infection.
Sofosbuvir is white to off-white crystalline solid and slightly soluble in water.
CAS NO.: 1029877-94-8
Notice: If the compound involved in patent protection, do not use for commercial purposes, and only for the purpose of analysis and research experiments. If it’s sold to countries which constitute patent infringement, All the risks corresponding are unrelated to our company